Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity

Sorafenib is a small, orally-active multikinase inhibitor that is most frequently used for the management of renal cell carcinoma, hepatocellular carcinoma, and radioactive iodine-resistant thyroid carcinoma. However, recent reports have associated sorafenib with hepatotoxicity that can limit its cl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxid Med Cell Longev
Autors principals: AlAsmari, Abdullah F., Ali, Nemat, AlAsmari, Fawaz, AlAnazi, Wael A., Alqahtani, Faleh, Alharbi, Metab, Alotaibi, Farraj M., Aldossari, Abdullah A., AlSwayyed, Mohammed, Alanazi, Mohammed M., Alshamrani, Ali A.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245685/
https://ncbi.nlm.nih.gov/pubmed/32509153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7453406
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars